Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction

The aim of this study was to evaluate the effects of Sacubitril/Valsartan (S/V) on clinical, laboratory and echocardiographic parameters and outcomes in a real-world population with heart failure with reduced ejection fraction (HFrEF). This was a prospective observational study enrolling patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Polito, Maria Vincenza, Silverio, Angelo, Rispoli, Antonella, Vitulano, Gennaro, Auria, Federica D’, De Angelis, Elena, Loria, Francesco, Gigantino, Alberto, Bonadies, Domenico, Citro, Rodolfo, Carrizzo, Albino, Galasso, Gennaro, Iaccarino, Guido, Vecchione, Carmine, Ciccarelli, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170843/
https://www.ncbi.nlm.nih.gov/pubmed/32313194
http://dx.doi.org/10.1038/s41598-020-63801-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170843/
https://www.ncbi.nlm.nih.gov/pubmed/32313194
http://dx.doi.org/10.1038/s41598-020-63801-2

Ejemplares similares